Do the melanophore dispersing hormones pass the cerebrospinal fluid-blood barrier of the killifish, Fundulus heteroclitus?

Central and peripheral administration of endothelin-1 induces an increase in blood pressure in conscious trout

The central and peripheral cardiovascular effects of endothelin (ET)-1 and ET-3 were investigated in conscious rainbow trout. Both intracerebroventricular and intra-arterial injections of ET-1 (6. 25-25 pmol) but not ET-3 (25 pmol) caused a dose-dependent increase in mean dorsal aortic blood pressure and a concomitant decrease in heart rate. The hypertensive effects induced by intra-arterial and intracerebroventricular injection of ET-1 were associated with a significant (P < 0.05) increase in systemic vascular resistance. Intracerebroventricular injection of ET-1 induced a twofold higher pressor response than that caused by intra-arterial injection of ET-1 and provoked a barostatic gain that was reduced by 2.5- to 3-fold compared with that calculated after intra-arterial administration of the peptide. The ET receptor antagonist bosentan significantly (P < 0.05) attenuated these responses regardless of the route of administration. Finally, intra-arterial injection of ET-1 did not significantly modify plasma cortisol level. The present data demonstrate that intracerebroventricular and intra-arterial administration of very low doses of ET-1 produces hypertension in conscious trout. The lack of effect of ET-3 indicates that the hemodynamic actions of ET-1 are mediated both centrally and peripherally through ETA receptors.

Intracerebroventricular injection of arginine vasotocin induces elevation of blood pressure in anesthetized trout

The present investigation assessed the ability of the neurohypophysial nonapeptide arginine vasotocin (AVT) to centrally regulate the cardiovascular activity in fish. Intracerebroventricular (ICV) injection of AVT (0.4 to 50 ng/kg b.wt.) in anesthetized trout resulted in a dose-related increase in blood pressure (BP) without any consistent changes in heart rate. For doses of AVT ranging from 2 to 50 ng/kg b.wt., BP remained elevated during at least 25 min after ICV injection. Systemic (intraarterial) administration of the same doses of AVT appeared to be less efficient than ICV injection, except for the highest dose (50 ng/kg) which evoked a similar rise in BP as that observed after ICV administration. In contrast to AVT, a high concentration of neuropeptide Y (10 micrograms/kg b.wt., ICV) caused only a slight increase of BP. The results suggest that AVT acts centrally to regulate BP in fish. These data, together with the widespread distribution of AVT-immunoreactive fibers and AVT binding sites in the brain, support the notion that, in fish, AVT may play neuromodulator and/or neurotransmitter functions.

Hormonal control of sleep-appetitive behaviour and diurnal activity rhythms in the cleaner wrasse Labroides dimidiatus (Labridae, Teleostei)

In its natural environment the cleaner wrasse, Labroides dimidiatus, possesses a hiding place in the reef, where it disappears every night. In my experiments, the Labroides was offered a specific sleeping cave in tanks. Photocells at the entrance to each cave, connected to a printer, counted the sleep-appetitive behaviour (SAB), viz. the investigation of the sleeping-place. Untreated animals visited the cave 45.6 times within 90 min prior to darkness. The swimming activity, which was measured 3 times daily, declined in the course of the light period. During the night the animals are totally motionless. Four substances which are involved in the sleep-influencing processes in mammals were tested. Injection of the neurotransmitter serotonin (0.05-0.5 micrograms/g b.wt. 5-HT) resulted in a decrease of swimming activity and SAB; the 5-HT blocking substance p-chlorophenylalanine (1-8 micrograms/g b.wt. PCPA) intensified this activity and suppressed SAB only in a concentration-range of 10 and 12 micrograms/g b.wt. In addition, the neuromodulatory properties of vasoactive intestinal polypeptide (VIP) and arginine vasotocin (AVT) were investigated. It is noteworthy to mention that VIP (1-1.5 micrograms/g b.wt.) lead to an remarkable increase, and AVT (0.5-4 micrograms/g b.wt.) to a significant reduction of the SAB.